Engineering of microcomplex of artemether and lumefantrine for effective drug treatment in malaria
Source abstract
Abstract
The objective of the present work was to engineer and characterize stable citric acid cross-linked microcomplex of the inclusion complexes of artemether with β-cyclodextrin and Kollidon VA 64® with lumefantrine to release the drugs in controlled manner for effective combinational drug treatment in malaria. The microcomplex had a hydrodynamic diameter of 1047 ± 147 nm with surface charge of −19.7 ± 0.5 mV. The microcomplex showed high encapsulation efficiencies 85.6 ± 1.78% for artemether and 91.16 ± 2.21% for lumefantrine due to the lipophilic nature of drugs. In-vitro and in-vivo drug release studies showed the controlled release of artemether and lumefantrine for a period of 24 h.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Advanced Drug Delivery Systems · Lipid Membrane Structure and Behavior · Malaria Research and Control
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Shobhaben Pratapbhai Patel School of Pharmacy and Technology Management, SVKM’s NMIMS University, Mumbai, India
References (17)
Show source-provided references
1. 10.3109/21691401.2014.96882110.3109/21691401.2014.968821 ↗
2. 10.4084/mjhid.2012.06010.4084/mjhid.2012.060 ↗
3. 10.1590/S1984-8250200900040001810.1590/S1984-82502009000400018 ↗
4. 10.1007/s40005-013-0078-z10.1007/s40005-013-0078-z ↗
5. 10.1016/j.jeurceramsoc.2011.08.01510.1016/j.jeurceramsoc.2011.08.015 ↗
6. Laxmi M · Nanomed Biotechnol · 2014 · 43 · 334
7. Malaria Fact sheet N°94. WHO. March 2014; Available from: http://www.who.int/malaria/media/world_malaria_report_2014/en/. [cited 2014 Aug 28].
8. World Health Organization. 2010. Guidelines for the Treatment of Malaria (2nd ed.). Geneva: World Health Organization, p. ix.
9. Margret R · J Pharm Res · 2014 · 8 · S1467
10. Olumide SA · J Reprod Infertil · 2011 · 12 · 249
11. 10.4103/0975-7406.9415510.4103/0975-7406.94155 ↗
12. Sandhya SM · Indo Am J Pharm Sci · 2015 · 5 · 720
13. 10.1007/s10847-012-0140-x10.1007/s10847-012-0140-x ↗
14. 10.1016/j.ijpharm.2013.08.01210.1016/j.ijpharm.2013.08.012 ↗
15. 10.1016/j.bmc.2009.07.06010.1016/j.bmc.2009.07.060 ↗
16. WHO List of Essential Medicines, 18th list, April 2013.
17. WHO Technical Report Series 937. 2006. Annex 8: Proposal to waive in vivo bioequivalence requirements for WHO Model List of Essential Medicines immediate-release, solid oral dosage forms.